Protein pathway activation associated with sustained virologic response in patients with chronic hepatitis C treated with pegylated interferon (PEG-IFN) and ribavirin (RBV)
Zobair M. Younossi, Dolores Limongi, Maria Stepanova, Mariaelena Pierobon, Arian Afendy, Rohini Mehta, Ancha Baranova, Lance Liotta, Emanuel Petricoin
Research output: Contribution to journal › Article › peer-review
11Scopus
citations
Fingerprint
Dive into the research topics of 'Protein pathway activation associated with sustained virologic response in patients with chronic hepatitis C treated with pegylated interferon (PEG-IFN) and ribavirin (RBV)'. Together they form a unique fingerprint.